Clinical trial NCT05864846
Status: Completed, results awaitedPhase 4Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
- Record number
- NCT05864846
- Status
- Completed, results awaited
- Type and phase
- Clinical trial, phase 4
- Participants
- 79 (actual)
- Condition (as registered)
- Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
- Countries
- Canada, Poland, United Kingdom, United States
- Topic in the guide
- Tuberous Sclerosis
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: June 29, 2023
- End of data collection for primary results: April 6, 2026
- Trial completion: April 6, 2026
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Completed, results awaited.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Tuberous Sclerosis: ongoing trials · Thinking of taking part? Which specialist to see